• Federated Hermes reports 17.17% stake in Minerva (NASDAQ: NERV) Stock Titan Wed, 08 Jul 2026 11:52:07 GMT
• Minerva Neurosciences (NERV) Slides 3.15% as Stock Tests Key Support at $4.52 - Iron Condor Alert dars.gov.et Tue, 07 Jul 2026 17:36:45 GMT
• Minerva Neurosciences, Inc.(NasdaqCM: NERV) added to Russell 2000 Value Benchmark marketscreener.com Mon, 29 Jun 2026 15:07:47 GMT
• Minerva Neurosciences, Inc.(NasdaqCM:NERV) added to Russell 3000E Growth Benchmark marketscreener.com Mon, 29 Jun 2026 04:12:44 GMT
• Minerva Neurosciences, Inc.(NasdaqCM: NERV) added to Russell 2500 Value Benchmark marketscreener.com Sun, 28 Jun 2026 22:00:00 GMT
• Price to sales forward of Minerva Neurosciences, Inc – NASDAQ:NERV TradingView Sun, 28 Jun 2026 18:13:53 GMT
• Minerva Neurosciences, Inc.(NasdaqCM:NERV) added to Russell Small Cap Completeness Index marketscreener.com Sun, 28 Jun 2026 07:00:00 GMT
• minerva neurosciences inc actuals & estimates (nasdaq:nerv) TradingView Sat, 27 Jun 2026 01:19:15 GMT
• minerva neurosciences inc actuals & estimates (boats:nerv) TradingView Fri, 26 Jun 2026 07:48:24 GMT
• minerva neurosciences inc (nerv) valuation: pe, pb & fair value analysis TradingKey Fri, 26 Jun 2026 07:00:00 GMT
• minerva neurosciences inc (nerv) risk assessment: volatility, financial risk & investment risk TradingKey Fri, 26 Jun 2026 07:00:00 GMT
• minerva neurosciences inc actuals & estimates (swb:4mna) TradingView Fri, 26 Jun 2026 04:40:15 GMT
• price to book forward of minerva neurosciences, inc – nasdaq:nerv TradingView Fri, 26 Jun 2026 01:35:58 GMT
• minerva neurosciences inc (nerv) valuation: pe, pb & fair value analysis TradingKey Wed, 24 Jun 2026 07:00:00 GMT
• minerva neurosciences inc (nerv) risk assessment: volatility, financial risk & investment risk TradingKey Wed, 24 Jun 2026 07:00:00 GMT
• minerva neurosciences inc (nerv) technical analysis: support, resistance, indicators & moving averages TradingKey Tue, 23 Jun 2026 07:00:00 GMT
• minerva neurosciences inc (nerv) shareholder structure: major shareholders & institutional holdings TradingKey Thu, 18 Jun 2026 08:20:47 GMT
• minerva neurosciences inc (nerv) valuation: pe, pb & fair value analysis TradingKey Thu, 18 Jun 2026 07:02:14 GMT
• minerva neurosciences inc (nerv) financial health: profitability & balance sheet analysis TradingKey Thu, 18 Jun 2026 06:55:21 GMT
• minerva neurosciences inc (nerv) technical analysis: support, resistance, indicators & moving averages TradingKey Thu, 18 Jun 2026 06:52:30 GMT
• minerva neurosciences inc (nerv) earnings forecast: future eps & revenue growth estimates TradingKey Thu, 18 Jun 2026 06:50:21 GMT
• Minerva Neurosciences Inc (NERV) Dividends & Stock Splits: Historical Payouts and Event Timeline TradingKey Thu, 18 Jun 2026 06:23:26 GMT
• minerva neurosciences inc (nerv) institutional confidence TradingKey Thu, 18 Jun 2026 06:22:59 GMT
• minerva neurosciences inc (nerv) risk assessment: volatility, financial risk & investment risk TradingKey Thu, 18 Jun 2026 06:19:41 GMT
• Minerva Neurosciences Inc (NERV) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution TradingKey Thu, 18 Jun 2026 06:11:53 GMT
• minerva neurosciences inc (nerv) earnings forecast: future eps & revenue growth estimates TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• minerva neurosciences (nerv) holds near support after modest decline: key levels in focus - mutual fund flow newsline.com Mon, 08 Jun 2026 16:44:30 GMT
• minerva neurosciences director granted 50,000 options | nerv insider trading Stock Titan Fri, 05 Jun 2026 22:00:07 GMT
• minerva neurosciences (nerv) loses 37.5% in 4 weeks, here's why a trend reversal may be around the corner MSN Fri, 05 Jun 2026 12:45:09 GMT
• Minerva Neurosciences grants 50,000 options to director | NERV Insider Trading Stock Titan Fri, 05 Jun 2026 07:00:00 GMT
• Minerva Neurosciences (NERV) CFO awarded 680,000 stock options at $4.6800 Stock Titan Fri, 05 Jun 2026 07:00:00 GMT
• Minerva Neurosciences (NERV) CEO granted 1.69M stock options at $4.68 strike Stock Titan Fri, 05 Jun 2026 07:00:00 GMT
• Minerva Neurosciences Inc Q1 2026 Earnings: EPS Misses Estimates, No Revenue Reported dars.gov.et Fri, 05 Jun 2026 07:00:00 GMT
• minerva neurosciences (nerv) awards 50,000 stock options to director Stock Titan Fri, 05 Jun 2026 07:00:00 GMT
• minerva neurosciences (nerv) grants director 50,000 stock options at $4.68 Stock Titan Fri, 05 Jun 2026 07:00:00 GMT
• minerva neurosciences (nerv) director receives stock options for 50,000 shares Stock Titan Fri, 05 Jun 2026 07:00:00 GMT
• minerva neurosciences (nerv) loses 37.5% in 4 weeks, here's why a trend reversal may be around the corner MSN Thu, 04 Jun 2026 12:37:35 GMT
• minerva neurosciences (nerv) holders approve officer shield, drop forum clause Stock Titan Thu, 04 Jun 2026 07:00:00 GMT
• nerv: roluperidone targets negative symptoms in schizophrenia, with pivotal data expected in 2027 TradingView Thu, 04 Jun 2026 07:00:00 GMT
• minerva neurosciences updates governance following 2026 shareholder meeting TipRanks Thu, 04 Jun 2026 07:00:00 GMT
• minerva neurosciences sets june 2026 date for annual stockholder meeting Investing.com Thu, 04 Jun 2026 07:00:00 GMT
• nerv q1 2026 earnings: wider-than-expected loss highlights ongoing development costs - healthcare earnings report newsline.com Wed, 03 Jun 2026 07:00:00 GMT
• Minerva Neurosciences Establishes Scientific Advisory Board to Advance Development of Roluperidone and Future Pipeline Programs GlobeNewswire Mon, 01 Jun 2026 07:00:00 GMT
• minerva neurosciences (nerv) holds near support after slight decline: key levels to watch - covered call trade newsline.com Fri, 29 May 2026 07:00:00 GMT
• minerva neurosciences announces sales agreement with leerink partners for common stock offering (form 8-k filing) Minichart Thu, 28 May 2026 11:20:00 GMT
• minerva neurosciences (nerv) edges lower near support level amid quiet trading - obv breakout newsline.com Thu, 28 May 2026 07:00:00 GMT
• minerva neurosciences (nerv) adds $75m atm program and lengthens key phase 3 c19 trial Stock Titan Wed, 27 May 2026 20:18:04 GMT
• hc wainwright & co. maintains minerva neurosciences (nerv) neutral recommendation MSN Wed, 27 May 2026 07:05:51 GMT
• minerva neurosciences - to offer and sell up to $75 million in common stock through leerink partners TradingView Wed, 27 May 2026 07:00:00 GMT
• minerva neurosciences (nasdaq: nerv) launches $75m at‑the‑market stock program Stock Titan Wed, 27 May 2026 07:00:00 GMT
• minerva neurosciences inc (nerv) q1 2026 earnings: wider loss highlights ongoing pre-revenue development stage - earnings surprise... newsline.com Mon, 25 May 2026 07:00:00 GMT
• minerva neurosciences q1 2026 earnings: eps misses estimates as clinical-stage biotech faces challenges - revenue beat analysis newsline.com Sun, 24 May 2026 07:00:00 GMT
• all you need to know about minerva neurosciences (nerv) rating upgrade to buy MSN Sun, 24 May 2026 00:13:35 GMT
• all you need to know about minerva neurosciences (nerv) rating upgrade to buy MSN Sat, 23 May 2026 00:13:12 GMT
• minerva neurosciences q1 2026 earnings: eps misses street estimates, stock gains on pipeline optimism - eps growth rate The Legal Advocate Fri, 22 May 2026 07:00:00 GMT
• minerva neurosciences (nerv) loses 37.5% in 4 weeks, here's why a trend reversal may be around the corner Yahoo Finance Wed, 20 May 2026 07:00:00 GMT
• all you need to know about minerva neurosciences (nerv) rating upgrade to buy Yahoo Finance Wed, 20 May 2026 07:00:00 GMT
• minerva neurosciences (nerv) stock: up +15.60%, key resistance at $5.29 2026-05-20 - dividend arbitrage The Legal Advocate Wed, 20 May 2026 07:00:00 GMT
• minerva neurosciences rises on financing of up to $200m to advance schizophrenia drug MSN Tue, 19 May 2026 14:54:06 GMT
• minerva neurosciences to present at 2026 jefferies global healthcare conference geneonline.com Tue, 19 May 2026 07:00:00 GMT
• Minerva Neurosciences to Participate in the 2026 Jefferies Global Healthcare Conference Yahoo Finance Mon, 18 May 2026 07:00:00 GMT
• Minerva CEO to join Jefferies 2026 healthcare fireside chat June 4 Stock Titan Mon, 18 May 2026 07:00:00 GMT
• minerva neurosciences (nerv) q1 2026 earnings: miss sparks concern - balance sheet strength newsline.com Mon, 18 May 2026 07:00:00 GMT
• minerva neurosciences rises on financing of up to $200m to advance schizophrenia drug MSN Sun, 17 May 2026 22:19:07 GMT
• minerva neurosciences (nerv) price target increased by 31.03% to 9.69 MSN Sun, 17 May 2026 11:44:13 GMT
• minerva neurosciences (nerv) slides -5.22% as selling pressure mounts 2026-05-15 - volatility term structure newsline.com Fri, 15 May 2026 07:00:00 GMT
• minerva neurosciences launches key phase 3 test for roluperidone in schizophrenia TipRanks Fri, 15 May 2026 07:00:00 GMT
• janus henderson (nerv) reports 4.3m shares, 9.9% stake disclosed Stock Titan Fri, 15 May 2026 07:00:00 GMT
• balyasny group (nasdaq: nerv) discloses a 9.99% stake of 4.32m shares Stock Titan Fri, 15 May 2026 07:00:00 GMT
• minerva neurosciences (nerv) price target increased by 31.03% to 9.69 MSN Fri, 15 May 2026 03:56:02 GMT
• minerva neurosciences rises on financing of up to $200m to advance schizophrenia drug MSN Fri, 15 May 2026 01:53:22 GMT
• minerva neurosciences (nerv) slips -0.90%, testing $5.22 support 2026-05-14 - dividend etf newsline.com Thu, 14 May 2026 07:00:00 GMT
• minerva neurosciences (nerv) price target increased by 31.03% to 9.69 MSN Wed, 13 May 2026 06:48:50 GMT
• h.c. wainwright maintains minerva neurosciences(nerv.us) with hold rating, raises target price to $7 Moomoo Mon, 11 May 2026 10:33:00 GMT
• tsao maintains hold on minerva as roluperidone phase 3 progress balances rising losses; $7 price target reaffirmed TipRanks Mon, 11 May 2026 07:00:00 GMT
• minerva neurosciences, inc. reports earnings results for the first quarter ended march 31, 2026 marketscreener.com Tue, 05 May 2026 12:31:00 GMT
• press release: minerva neurosciences provides first quarter 2026 financial results and business updates Moomoo Tue, 05 May 2026 12:00:00 GMT
• Minerva Neurosciences, Inc. 1Q 2026: Revenue $0 Net loss $(125.4M), EPS $(2.86) — 10-Q Summary TradingView Tue, 05 May 2026 07:00:00 GMT
• Minerva Neurosciences Provides First Quarter 2026 Financial Results and Business Updates The Manila Times Tue, 05 May 2026 07:00:00 GMT
• no approved drug targets these schizophrenia symptoms; phase 3 starts Stock Titan Tue, 05 May 2026 07:00:00 GMT
• minerva neurosciences starts phase 3 trial for roluperidone to treat negative schizophrenia symptoms Pluang Tue, 05 May 2026 07:00:00 GMT
• phase 3 roluperidone trial and larger q1 loss at minerva (nerv) Stock Titan Tue, 05 May 2026 07:00:00 GMT
• minerva neurosciences (nerv) posts large q1 2026 non-cash loss but keeps cash runway Stock Titan Tue, 05 May 2026 07:00:00 GMT
• 8-k: minerva neurosciences provides first quarter 2026 financial results and business updates - moomoo Moomoo Tue, 05 May 2026 07:00:00 GMT
• minerva neurosciences posts 1q $109.4m non-cash expense for change in fair value of warrant liability, losses recognized upon exer... Moomoo Tue, 05 May 2026 07:00:00 GMT
• schizophrenia market: investment-ready growth trends to 2034 – delveinsight | teva pharma, royalty pharma, medincell, sumitomo pha... Barchart Fri, 01 May 2026 12:20:24 GMT
• minerva neurosciences, inc (nasdaq:nerv) short interest update MarketBeat Fri, 01 May 2026 07:00:00 GMT
• minerva neurosciences (nerv) price target increased by 31.03% to 9.69 MSN Thu, 30 Apr 2026 18:11:50 GMT
• minerva launched with new outperform at citizens on schizophrenia candidate MSN Thu, 30 Apr 2026 06:53:04 GMT
• minerva neurosciences (nerv) price target increased by 31.03% to 9.69 MSN Tue, 28 Apr 2026 10:02:23 GMT
• minerva launched with new outperform at citizens on schizophrenia candidate MSN Tue, 28 Apr 2026 03:13:45 GMT
• minerva launched with new outperform at citizens on schizophrenia candidate MSN Mon, 27 Apr 2026 20:49:50 GMT
• citizens initiates coverage of minerva neurosciences (nerv) with market outperform recommendation MSN Mon, 27 Apr 2026 06:44:32 GMT
• nerv sec filings - minerva neurosci 10-k, 10-q, 8-k forms Stock Titan Sat, 25 Apr 2026 13:39:40 GMT
• minerva launched with new outperform at citizens on schizophrenia candidate MSN Fri, 24 Apr 2026 07:13:42 GMT
• officer liability and pay votes at minerva neurosciences (nasdaq: nerv) 2026 meeting Stock Titan Thu, 23 Apr 2026 07:00:00 GMT
• nerv (minerva neurosciences inc) posts wider than expected q4 2025 loss yet shares rise 5.28 percent on bullish investor sentiment... UBND thành phố Hải Phòng Thu, 23 Apr 2026 04:07:36 GMT
• minerva launched with new outperform at citizens on schizophrenia candidate MSN Wed, 22 Apr 2026 17:34:23 GMT
• [form 4] minerva neurosciences, inc. insider trading activity Stock Titan Wed, 22 Apr 2026 07:00:00 GMT
• minerva neurosciences (nerv) officer james o’connor files form 3 Stock Titan Wed, 22 Apr 2026 07:00:00 GMT
• minerva launched with new outperform at citizens on schizophrenia candidate MSN Mon, 20 Apr 2026 23:32:35 GMT
• minerva launched with new outperform at citizens on schizophrenia candidate MSN Sun, 19 Apr 2026 14:05:42 GMT
• minerva launched with new outperform at citizens on schizophrenia candidate MSN Fri, 17 Apr 2026 23:14:53 GMT
• minerva launched with new outperform at citizens on schizophrenia candidate MSN Thu, 16 Apr 2026 16:18:57 GMT
• nerv initiates coverage on citizens -- rating set to market outp GuruFocus Wed, 15 Apr 2026 15:17:34 GMT
• minerva neurosciences (nasdaq:nerv) now covered by citizens jmp MarketBeat Wed, 15 Apr 2026 13:23:45 GMT
• Minerva stock wins New Outperform at Citizens (NERV:NASDAQ) Seeking Alpha Wed, 15 Apr 2026 07:00:00 GMT
• nerv (minerva neurosciences inc) posts wider than expected q4 2025 loss yet shares rise 5.28 percent on bullish investor sentiment... The Legal Advocate Wed, 15 Apr 2026 07:00:00 GMT
• citizens initiates minerva neurosciences stock at outperform, $14 target by investing.com Investing.com UK Wed, 15 Apr 2026 07:00:00 GMT
• citizens initiates coverage of minerva neurosciences (nerv) with market outperform recommendation MSN Wed, 15 Apr 2026 07:00:00 GMT
• nrg fusion market competitive landscape report 2026 featuring zensun (shanghai) sci & tech, salubris biotherapeutics, hummingbird ... Yahoo Finance Mon, 13 Apr 2026 07:00:00 GMT
• minerva neurosciences, inc (nasdaq:nerv) sees significant growth in short interest MarketBeat Mon, 13 Apr 2026 07:00:00 GMT
• retail surge: is minerva neurosciences inc stock technically oversold - 2026 breakouts & breakdowns & weekly watchlist of top perf... baoquankhu1.vn Sun, 12 Apr 2026 01:59:39 GMT
• minerva neurosciences (nasdaq: nerv) proxy: charter amendments, say‑on‑pay vote Stock Titan Fri, 10 Apr 2026 07:00:00 GMT
• minerva neurosciences (nasdaq:nerv) shares cross below fifty day moving average - should you sell? MarketBeat Wed, 08 Apr 2026 07:00:00 GMT
• Minerva Screens First Patient in Phase 3 Schizophrenia Trial The Clinical Trial Vanguard Tue, 07 Apr 2026 07:00:00 GMT
• minerva neurosciences, inc. files form 8-k with sec – company information and key details (april 6, 2026) 14 Minichart Tue, 07 Apr 2026 07:00:00 GMT
• minerva neurosciences sets 2026 annual shareholder meeting timeline The Globe and Mail Tue, 07 Apr 2026 07:00:00 GMT
• minerva neurosciences sets june 2026 date for annual stockholder meeting by investing.com Investing.com India Tue, 07 Apr 2026 07:00:00 GMT
• nerv sec filings - minerva neurosci 10-k, 10-q, 8-k forms Stock Titan Mon, 06 Apr 2026 23:18:07 GMT
• ideas watch: is minerva neurosciences inc stock a hidden gem - portfolio gains report & real-time stock entry alerts baoquankhu1.vn Mon, 06 Apr 2026 19:25:42 GMT
• minerva neurosciences sets june 2026 date for annual stockholder meeting Investing.com Mon, 06 Apr 2026 07:00:00 GMT
• minerva neurosciences (nasdaq: nerv) sets 2026 meeting and proposal deadlines Stock Titan Mon, 06 Apr 2026 07:00:00 GMT
• minerva neurosciences sets june 3, 2026 annual meeting; stockholder notice deadlines announced TradingView Mon, 06 Apr 2026 07:00:00 GMT
• minerva neurosciences sets 2026 annual shareholder meeting timeline TipRanks Mon, 06 Apr 2026 07:00:00 GMT
• minerva neurosciences appoints new chief business officer, counsel The Globe and Mail Fri, 03 Apr 2026 07:00:00 GMT
• minerva neurosciences names jim o’connor as chief business officer by investing.com Investing.com India Fri, 03 Apr 2026 07:00:00 GMT
• minerva neurosciences appoints dr. sheila o’connor as president and ceo following leadership transition geneonline.com Thu, 02 Apr 2026 21:35:56 GMT
• Minerva Appoints Jim O’Connor as Chief Business Officer and General Counsel citybiz Thu, 02 Apr 2026 07:00:00 GMT
• minerva neurosciences names jim o’connor as chief business officer Investing.com Thu, 02 Apr 2026 07:00:00 GMT
• leadership shift at minerva neurosciences (nasdaq: nerv) as o’connor joins Stock Titan Thu, 02 Apr 2026 07:00:00 GMT
Minerva Neurosciences, Inc(NASDAQ:NERV) 
Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone, a compound in Phase III clinical trial for the treatment o...
Website: http://www.minervaneurosciences.com
Founded: 2007
Full Time Employees: 13
Sector: Healthcare
Industry: Biotechnology